UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus 4.5 achieved a No. 1 ranking on the OSWorld-Verified benchmark, an ...
Quick Summary ChatGPT thinks UiPath stock could drift lower over the next 60 days, projecting a move toward roughly $16.20 by ...
UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...
Zacks Investment Research on MSN
UiPath is regaining market confidence: What should investors do next?
UiPath’s PATH stock rebound reflects rising confidence in its strengthening fundamentals and long-term AI automation ...
Zacks Investment Research on MSN
UiPath (PATH) stock sinks as market gains: Here's why
UiPath (PATH) closed at $14.79 in the latest trading session, marking a -3.77% move from the prior day. This change lagged ...
MINNEAPOLIS--(BUSINESS WIRE)--Deluxe, a trusted Payments and Data company, today announced it has been named an UiPath AI25 Award Winner. The annual award program identifies the 25 most innovative ...
UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean ...
These high-risk, high-reward stocks could generate huge gains if they can become market leaders in their respective fields.
Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...
Figma went public at $33 last July and currently trades at approximately $37. UiPath went public at $56 in April 2021, but it ...
Payments and data company recognized as one of the 25 most innovative UiPath customers using AI and automation The UiPath AI25 Awards acknowledge customers using AI and automation to supercharge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback